Filing Details
Replimune Group, Inc. (NASDAQ:REPL) filed a Form 8-K with the Securities and Exchange Commission on July 30, 2026, disclosing a material event.
8k filedNASDAQ:REPL
Replimune Group, Inc. (REPL) Reports Material Event to SEC
Filing Details Replimune Group, Inc. (NASDAQ:REPL) filed a Form 8-K with the Securities and Exchange Commission on July 30, 2026, disclosing a material event. Market Context…
Market Context
Replimune Group, Inc.'s stock currently trades at $5.41 with a market capitalization of $774.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Replimune Group, Inc.'s stock.
All SEC filings for Replimune Group, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View REPL Stock Page
Frequently Asked Questions
Where can I read REPL's SEC filings?
Browse all filings on our REPL SEC filings page.
What types of SEC filings does Replimune Group, Inc. file?
Public companies like Replimune Group, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.